(90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3)

Research output: Contribution to journalPublished meeting abstract


  • Arne Kolstad
  • Anna Laurell
  • Niels S. Andersen
  • Erkki Elonen
  • Riikka Raty
  • Lone Bredo Pedersen
  • Annika Loft
  • Trond Velde Bogsrud
  • Marie Nordstrom
  • Dorte Gillstrom
  • Per Boye Hansen
  • Hans Bentzen
  • Unn-Merete Fagerli
  • Peter Meyer
  • Herman Nilsson-Ehle
  • Anne Kristine Lehmann
  • Grete F. Lauritzsen
  • Christer Sundstrom
  • Jan Delabie
  • Marja-Liisa Karjalainen-Lindsberg
  • Elisabeth Ralfkiaer
  • Christian H. Geisler
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Hematology
Original languageEnglish
Pages (from-to)384-384
Issue number22
Publication statusPublished - 2009
Publication categoryResearch
Event51st Annual Meeting of the American-Society-of-Hematology - New Orleans, LA
Duration: 2009 Dec 52009 Dec 8

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Oncology, MV (013035000), Pathology, (Lund) (013030000)